4//SEC Filing
Pauls Dietrich John 4
Accession 0001235802-21-000092
CIK 0001401040other
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 9:07 PM ET
Size
6.2 KB
Accession
0001235802-21-000092
Insider Transaction Report
Form 4
Pauls Dietrich John
DirectorPresident & CEO
Transactions
- Award
Stock Option (right to buy)
2021-07-28+175,000→ 175,000 totalExercise: $5.00Exp: 2031-07-27→ Common Shares (175,000 underlying)
Holdings
- 30,804
Voting Common Shares, no par value per share
Footnotes (2)
- [F1]Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.
- [F2]Vests in sixteen nearly equal quarterly installments over four years.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001760123
Filing Metadata
- Form type
- 4
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 9:07 PM ET
- Size
- 6.2 KB